The global proton pump inhibitors (PPIs) market, valued at $3.7 billion in 2023, is poised to grow at a compound annual growth rate (CAGR) of 4.0%, reaching more than $5.6 billion by 2034, according to the latest market analysis. The growth is primarily driven by the rising prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and Helicobacter...